For once, this isn’t hyperbole. Metastatic pancreatic cancer hasn’t had a meaningful new treatment in literally decades - it’s been brutal chemotherapy or slightly less brutal chemotherapy.
The new generation of KRAS inhibitors, of which daraxonrasib is just the first to make it to approval, is genuinely a practice-changing breakthrough.
It won’t cure people with metastatic disease, but it will help a lot live better lives for longer.
233mhz 19 minutes ago [-]
> For once, this isn’t hyperbole.
Am I missing something?
From other sources:
> Median overall survival: 13.2 months versus about 6.6 to 6.7 months with chemotherapy.
scarmig 16 minutes ago [-]
Doubling life expectancy on a form of cancer infamous as a death sentence.
shevy-java 7 minutes ago [-]
I don't see that as a breakthrough.
Merely counting months does not do much - you'd have to count the quality of these months too.
simtel20 2 minutes ago [-]
Often pancreatic cancer is discovered only after it has spread. If this can treat it at that point it turns the disease from a death sentence to a lifeline until more research can come to fruition
maxerickson 2 minutes ago [-]
An effect that large is a medical breakthrough regardless of your opinion of the treatment impact.
tedggh 12 minutes ago [-]
Everything is relative. A few more months of life with less pain and more energy to spend it with family surely is a breakthrough for many patients and for the doctors treating them.
shevy-java 6 minutes ago [-]
But where does it imply less pain? Plus, which pain exactly? Chemotherapy also leads to pain. Prolonging treatment can cause more pain then.
I don't see that as a breakthrough.
bonsai_spool 5 minutes ago [-]
That’s like a 100% increase over standard of care. Or a two-order-of-magnitude improvement.
dang 31 minutes ago [-]
In case others are wondering, it looks like this is a different story than this recent one:
The new generation of KRAS inhibitors, of which daraxonrasib is just the first to make it to approval, is genuinely a practice-changing breakthrough.
It won’t cure people with metastatic disease, but it will help a lot live better lives for longer.
Am I missing something?
From other sources:
> Median overall survival: 13.2 months versus about 6.6 to 6.7 months with chemotherapy.
Merely counting months does not do much - you'd have to count the quality of these months too.
I don't see that as a breakthrough.
Pancreatic cancer halted by virus injection in three patients - https://news.ycombinator.com/item?id=50563066 - Nov 2026 (157 comments)